AbbVie
ABBV
#25
Rank
NZ$899.42 B
Marketcap
NZ$508.98
Share price
-0.14%
Change (1 day)
29.37%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

ESG Reports

Thumbnail AbbVie ESG Report 2025

ESG Report 2025

Language: English

View ESG Report
Thumbnail AbbVie ESG Report 2024

ESG Report 2024

Language: English

View ESG Report
Thumbnail AbbVie ESG Report 2023

ESG Report 2023

Language: English

View ESG Report
Thumbnail AbbVie ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail AbbVie ESG Report 2021

ESG Report 2021

Language: English

View ESG Report
Thumbnail AbbVie ESG Report 2020

ESG Report 2020

Language: English

View ESG Report